Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Results 41 - 50 of 83 for ssrx. (0.09 seconds)

3SBio announced a new investment partnership, called...
Shanghai Pharma is seeking to acquire a mid-sized US or...
Shanghai Duyiwei Biotechnology, a subsidiary of Gansu...
3SBio will form a $20 million JV with DaVita Inc., a...
Abcam will pay $170 million to buy Epitomics, a US mAb...
3SBio received permission from the SFDA to conduct the...
China plans to spend $11.8 billion to increase biopharma...
3SBio filed an Investigational New Drug (IND) application...
Hangzhou Tigermed Consulting, a clinical-stage CRO,...
3SBio, a China biotech, received an offer to take the...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here